BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6658017)

  • 1. The effects of thyrotropin-releasing hormone, metabolites and analogues on locomotor activity in rats.
    Andrews JS; Sahgal A
    Regul Pept; 1983 Oct; 7(2):97-109. PubMed ID: 6658017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of thyrotropin releasing hormone on rats with lesions of the mesolimbic and nigrostriatal dopamine systems.
    Andrews JS; Sahgal A
    Physiol Behav; 1985 Jul; 35(1):93-7. PubMed ID: 2997819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol-induced locomotor stimulation in rats after thyrotropin-releasing hormone.
    Breese GR; Coyle S; Towle AC; Mueller RA; McCown TJ; Frye GD
    J Pharmacol Exp Ther; 1984 Jun; 229(3):731-7. PubMed ID: 6427448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of wet-dog shaking in rats by analogues and metabolites of thyrotrophin-releasing hormone (TRH).
    Webster VA; Griffiths EC; Slater P
    Regul Pept; 1982 Dec; 5(1):43-51. PubMed ID: 6820171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues.
    Sharp T; Bennett GW; Marsden CA; Tulloch IF
    Regul Pept; 1984 Nov; 9(4):305-15. PubMed ID: 6441196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues.
    Ogawa N; Mizuno S; Mori A; Nukina I; Ota Z; Yamamoto M
    Peptides; 1984; 5(4):743-6. PubMed ID: 6436797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system.
    Kalivas PW; Stanley D; Prange AJ
    Neuropharmacology; 1987 Jan; 26(1):33-8. PubMed ID: 3104814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesolimbic involvement in the locomotor stimulant action of thyrotropin-releasing hormone (TRH) in rats.
    Miyamoto M; Nagawa Y
    Eur J Pharmacol; 1977 Jul; 44(2):143-52. PubMed ID: 407089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural and biochemical evidence for the release of noradrenaline in mouse brain by TRH and some of its biologically stable analogues.
    Heal DJ; Stoodley N; Elliott JM; Marsden CA; Bennett GW; Youdim MB
    Neuropharmacology; 1987 Apr; 26(4):313-22. PubMed ID: 2884590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of substance P, MIF, TRH and related peptides in the substantia nigra, caudate nucleus and nucleus accumbens.
    Pinnock RD; Woodruff GN; Turnbull MJ
    Neuropharmacology; 1983 Jun; 22(6):687-96. PubMed ID: 6193454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRH-induced behavioral arousal in developing rats pretreated with 6-hydroxydopa.
    Nomura Y; Oki K
    Pharmacol Biochem Behav; 1980 Jun; 12(6):925-30. PubMed ID: 6773071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny of thyrotropin-releasing hormone and histidyl proline diketopiperazine in the rat central nervous system and pancreas.
    Lamberton RP; Lechan RM; Jackson IM
    Endocrinology; 1984 Dec; 115(6):2400-5. PubMed ID: 6437798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analeptic effects of centrally injected TRH and analogues of TRH in the pentobarbitone-anaesthetized rat.
    Sharp T; Tulloch IF; Bennett GW; Marsden CA; Metcalf G; Dettmar PW
    Neuropharmacology; 1984 Mar; 23(3):339-48. PubMed ID: 6145113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sensitivity to the locomotor depressant effect of a dopamine receptor antagonist during cocaine withdrawal in the rat.
    Baldo BA; Markou A; Koob GF
    Psychopharmacology (Berl); 1999 Jan; 141(2):135-44. PubMed ID: 9952037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone.
    Okuda C; Mizobe T; Miyazaki M
    Life Sci; 1987 Mar; 40(13):1293-9. PubMed ID: 3104710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin releasing hormone but not histidyl-proline diketopiperazine is depleted from rat spinal cord following 5,7-dihydroxytryptamine treatment.
    Lechan RM; Jackson IM
    Brain Res; 1985 Feb; 326(1):152-5. PubMed ID: 3918765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): Involvement of the DA system in the locomotor stimulating action of TA-0910.
    Yamamura M; Kinoshita K; Nakagawa H; Ishida R
    Jpn J Pharmacol; 1991 Jan; 55(1):57-68. PubMed ID: 1904114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of thyrotropin-releasing hormone on the locomotor and sensitizing effects of cocaine in rats.
    Przegaliński E; Papla I; Czepiel K; Wydra K; Nowak E; Lasoń W; Filip M
    Neuropeptides; 2004 Feb; 38(1):48-54. PubMed ID: 15003716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of prolyl endopeptidase, pyroglutamyl peptidase I, TRH, and its metabolites in rat pancreas.
    Salers P; Ouafik LH; Giraud P; Maltese JY; Dutour A; Oliver C
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E845-50. PubMed ID: 1352085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin releasing hormone in the pancreas of newborn rats from streptozotocin-treated mothers.
    Strbák V; Ouafik LH; Resetková E; Oliver C; Giraud P; Dutour A; Salers P; Randusková A
    Life Sci; 1989; 44(12):779-87. PubMed ID: 2495394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.